Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2023-02-01
Seria:	Frontiers in Surgery
Hasła przedmiotowe:	low-grade glioma (WHO grade II) cost resection stereotactic biopsy adverse events—complications MarketScan database
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!